CompletedNCT02930005
Two Add-On Medicines for Psychosis: A Feasibility Study
About this title
Read the official source — NCT02930005Medication studyAges 18–60United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- HoustonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateAugust 7, 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- The University of Texas Health Science Center, Houston
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT02930005
- Official title
Show the full official title
A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Houston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center, Houston, a university.
Did this study involve medication?
Yes. The study involved medication, including Meclofenamic acid and Pentosan polysulfate sodium.
Who was this study for?
Listed age limits: 18 years to 60 years.
